Rural Health
Resources by Topic: Illicit drug use
Strategies Used to Reduce Harms Associated with Fentanyl Exposure among Rural People Who Use Drugs: Multi-Site Qualitative Findings from the Rural Opioid Initiative
Explores strategies utilized by rural people who use drugs to reduce fentanyl-related harm. Analyzes interviews with 349 people who recently used opioids or injection drugs in 10 states. Discusses awareness of fentanyl contamination, highlights perspectives on common harm reduction strategies, and describes public health applications. Includes state-by-state comparisons of participant demographic data.
Author(s): Suzan M. Walters, Robin Baker, David Frank, et al.
Citation: Harm Reduction Journal, 21, 154
Date: 08/2024
Type: Document
view details
Explores strategies utilized by rural people who use drugs to reduce fentanyl-related harm. Analyzes interviews with 349 people who recently used opioids or injection drugs in 10 states. Discusses awareness of fentanyl contamination, highlights perspectives on common harm reduction strategies, and describes public health applications. Includes state-by-state comparisons of participant demographic data.
Author(s): Suzan M. Walters, Robin Baker, David Frank, et al.
Citation: Harm Reduction Journal, 21, 154
Date: 08/2024
Type: Document
view details
Improving Access to Buprenorphine for Rural Veterans in a Learning Health Care System
Describes the development of a implementation strategy to increase rural buprenorphine prescribing at U.S. Department of Veteran Affairs (VA) healthcare systems based on existing successful strategies in 6 rural VAs. Discusses clinical needs to support increased prescribing related to mentorship, consulting services, and practitioner education.
Author(s): Jessica J. Wyse, Katherine Mackey, Kim A. Kauzlarich, et al.
Citation: Health Services Research, 2024
Date: 07/2024
Type: Document
view details
Describes the development of a implementation strategy to increase rural buprenorphine prescribing at U.S. Department of Veteran Affairs (VA) healthcare systems based on existing successful strategies in 6 rural VAs. Discusses clinical needs to support increased prescribing related to mentorship, consulting services, and practitioner education.
Author(s): Jessica J. Wyse, Katherine Mackey, Kim A. Kauzlarich, et al.
Citation: Health Services Research, 2024
Date: 07/2024
Type: Document
view details
Pain in the Nation 2024: The Epidemics of Alcohol, Drug, and Suicide Deaths
Report focuses on alcohol, drug, and mortality statistics and trends, with a special feature on polysubstance use and drug overdose issues. Includes data on substance use and mortality, with U.S. maps showing overdose and suicide rates, breakdowns according to race and metro versus nonmetro location, and state-by-state statistical trends. Provides policy recommendations to address substance use and offers examples from rural areas.
Author(s): Molly Warren, Brandon Reavis
Date: 07/2024
Type: Document
Sponsoring organization: Trust for America's Health
view details
Report focuses on alcohol, drug, and mortality statistics and trends, with a special feature on polysubstance use and drug overdose issues. Includes data on substance use and mortality, with U.S. maps showing overdose and suicide rates, breakdowns according to race and metro versus nonmetro location, and state-by-state statistical trends. Provides policy recommendations to address substance use and offers examples from rural areas.
Author(s): Molly Warren, Brandon Reavis
Date: 07/2024
Type: Document
Sponsoring organization: Trust for America's Health
view details
Community-Level Factors and their Associations with Changing Opioid Overdose Fatality Rates in Kentucky, 2019–2021
Identifies associations between community-level factors and opioid overdose fatality rates in Appalachian and non-Appalachian Kentucky counties, and examines how these associations have changed from 2019 to 2021. Discusses societal changes that occurred due to COVID-19, including social isolation, and which may be linked to an increase in overdose deaths. Features statistics with breakdowns by metropolitan, adjacent-to-metropolitan, and nonmetropolitan areas.
Author(s): Shawn R. Nigam, Philip M. Westgate, Svetla Slavova, Rachel Vickers-Smith, Katherine L. Thompson
Citation: Journal of Appalachian Health, 6(1), 90-115
Date: 07/2024
Type: Document
view details
Identifies associations between community-level factors and opioid overdose fatality rates in Appalachian and non-Appalachian Kentucky counties, and examines how these associations have changed from 2019 to 2021. Discusses societal changes that occurred due to COVID-19, including social isolation, and which may be linked to an increase in overdose deaths. Features statistics with breakdowns by metropolitan, adjacent-to-metropolitan, and nonmetropolitan areas.
Author(s): Shawn R. Nigam, Philip M. Westgate, Svetla Slavova, Rachel Vickers-Smith, Katherine L. Thompson
Citation: Journal of Appalachian Health, 6(1), 90-115
Date: 07/2024
Type: Document
view details
Expanding the Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through the RCORP Initiative
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health
Date: 07/2024
Type: Document
view details
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health
Date: 07/2024
Type: Document
view details
Addressing Opioid Misuse through Community-Engaged Strategy Development: Study Protocol of a Randomized Controlled Trial
Describes the design of a research study to evaluate the effectiveness of the SEED Method and a modified Delphi method for the recruitment of participants to a community-based participatory research project. Study participants will develop strategies to respond to the opioid epidemic in three rural Virginia communities.
Author(s): Emily B. Zimmerman, Carlin Rafie, Sophie G. Wenzel, et al.
Citation: Research Involvement and Engagement, 10, 74
Date: 07/2024
Type: Document
view details
Describes the design of a research study to evaluate the effectiveness of the SEED Method and a modified Delphi method for the recruitment of participants to a community-based participatory research project. Study participants will develop strategies to respond to the opioid epidemic in three rural Virginia communities.
Author(s): Emily B. Zimmerman, Carlin Rafie, Sophie G. Wenzel, et al.
Citation: Research Involvement and Engagement, 10, 74
Date: 07/2024
Type: Document
view details
Risk Factors for Persistent Fatal Opioid-Involved Overdose Clusters in Massachusetts 2011–2021: A Spatial Statistical Analysis with Socio-Economic, Accessibility, and Prescription Factors
Examines locations with high opioid-involved overdose deaths in Massachusetts as well as factors contributing to mortality, such as social infrastructure and opioid prescribing practices. Provides state maps showing opioid overdose rates according to ZIP Code Tabulation Area (ZCTA). Includes data on social infrastructure access, opioid prescriptions, and ZCTA clusters, with breakdowns by poverty and race.
Author(s): Sumeeta Srinivasan, Jennifer Pustz, Elizabeth Marsh, Leonard D. Young, Thomas J. Stopka
Citation: BMC Public Health, 24, 1893
Date: 07/2024
Type: Document
view details
Examines locations with high opioid-involved overdose deaths in Massachusetts as well as factors contributing to mortality, such as social infrastructure and opioid prescribing practices. Provides state maps showing opioid overdose rates according to ZIP Code Tabulation Area (ZCTA). Includes data on social infrastructure access, opioid prescriptions, and ZCTA clusters, with breakdowns by poverty and race.
Author(s): Sumeeta Srinivasan, Jennifer Pustz, Elizabeth Marsh, Leonard D. Young, Thomas J. Stopka
Citation: BMC Public Health, 24, 1893
Date: 07/2024
Type: Document
view details
Prescription Opioid Tapering Practices and Outcomes at a Rural VA Health Care System
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details